Interleukin 6 transsignaling is a candidate mechanism to drive progression of human DCCs during periods of clinical latency

Werner-Klein, Melanie and Grujovic, Ana and Obradovic, Milan and Hoffmann, Martin and Lu, Xin and Kirsch, Stefan and Treitschke, Steffi and Koestler, Caecilia and Weidele, Kathrin and Irlbeck, Christoph and Botteron, Catherine and Werno, Christian and Polzer, Bernhard and Guzvic, Miodrag and Buchholz, Stefan and Ruemmele, Petra and Heine, Norbert and Rose-John, Stefan and Klein, Christoph A. (2019) Interleukin 6 transsignaling is a candidate mechanism to drive progression of human DCCs during periods of clinical latency. CANCER RESEARCH, 79 (13Supp): LB-312. ISSN 0008-5472, 1538-7445

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Geburtshilfe)
Medicine > Lehrstuhl für experimentelle Medizin und Therapieverfahren
Depositing User: Petra Gürster
Date Deposited: 31 Mar 2020 12:19
Last Modified: 31 Mar 2020 12:19
URI: https://pred.uni-regensburg.de/id/eprint/26689

Actions (login required)

View Item View Item